Showing results (1301-1310 of 1,689) with videos related to

Sort By:
Pageof 169
Circulation. Heart Failure|April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure TrialEldrin F Lewis, Brian Claggett, Amil M Shah, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
Journal of the American Chemical Society|May 24, 2024
Chemoproteomics Identifies State-Dependent and Proteoform-Selective Caspase-2 InhibitorsJosé O Castellón, Samuel Ofori, Nikolas R Burton, et al.
JACC. Heart Failure|April 10, 2025
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Finnian R Mc Causland, Brian L Claggett, et al.
Applied Biochemistry and Biotechnology|October 5, 2013
Canine parvovirus type 2a (CPV-2a)-induced apoptosis in MDCK involves both extrinsic and intrinsic pathwaysJuwar Doley, Lakshya Veer Singh, G Ravi Kumar, et al.
BMC Medicine|July 15, 2015
Health and wealth in Mesoamerica: findings from Salud Mesomérica 2015Ali H Mokdad, Marielle C Gagnier, K Ellicott Colson, et al.
Circulation. Heart Failure|January 13, 2016
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure TrialSøren L Kristensen, David Preiss, Pardeep S Jhund, et al.
Journal of the American Heart Association|February 1, 2021
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HFSolmaz Ehteshami-Afshar, Leanne Mooney, Pooja Dewan, et al.
European Heart Journal|January 28, 2025
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trialAlexander Peikert, Muthiah Vaduganathan, Brian L Claggett, et al.
The Lancet. Diabetes & Endocrinology|January 16, 2025
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
Pageof 169